Association of blood manganese level with diabetes and renal dysfunction: a cross-sectional study of the Korean general population
1 Department of Internal Medicine, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seoul 137-701, Republic of Korea
2 Division of Nephrology, The Catholic University of Korea Yeouido St. Mary’s Hospital, 10, 63-ro, Yeongdeungpo-gu, Seoul 150-713, Republic of Korea
3 Division of Nephrology, The Catholic University of Korea Incheon St. Mary’s Hospital, 56, Dongsu-ro, Bupyeong-gu, Incheon 403-720, Republic of Korea
4 Department of Statistics, The Graduate School of Ewha Womans University, 52, Ewhayeodae-gil, Seodaemun-gu, Seoul 120-750, Republic of Korea
5 Division of Nephrology, The Catholic University of Korea Seoul St. Mary’s Hospital, 222, Banpo-daero, Seoul 137-701, Republic of Korea
BMC Endocrine Disorders 2014, 14:24 doi:10.1186/1472-6823-14-24Published: 8 March 2014
The purpose of this study was to evaluate the association between blood manganese levels and the prevalence of chronic diseases in the Korean population.
This was a cross-sectional study based on the Korean National Health and Nutrition Examination Survey (KNAHNES). The study included 3996 participants 20 years of age or older whose blood manganese levels had been measured. The participants were also evaluated for the presence of five chronic diseases: diabetes, renal dysfunction, hypertension, ischemic heart disease, and stroke.
Blood manganese levels were significantly lower in the diabetes group compared with the non-diabetes group (1.26 ± 0.02 vs. 1.35 ± 0.01 μg/dL; p = 0.001) and the renal dysfunction group compared with those with normal renal function (1.28 ± 0.03 vs. 1.35 ± 0.01 μg/dL; p = 0.04). There was no significant association between blood manganese levels and the presence of ischemic heart disease or stroke. A multivariate logistic regression analysis adjusted for age, sex, and body mass index was performed; the odds ratio was 0.652 (95% CI: 0.46–0.92) for diabetes and 0.589 (95% CI: 0.39–0.88) for renal dysfunction when comparing the higher quartiles (Q2-4) with the lowest quartile (Q1) of blood manganese level. The prevalence of diabetes was 7.6% in Q1 and 5.3% in Q2-4 (p = 0.02). Similarly, the prevalence of renal dysfunction was 6.8% in Q1, compared with 4.6% in Q2-4 (p = 0.02).
The prevalence of diabetes and renal dysfunction increased in participants with low blood manganese levels, suggesting that blood manganese may play a role in glucose homeostasis and renal function.